Corrigendum: IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel

Nat Commun. 2015 Nov 20:6:10054. doi: 10.1038/ncomms10054.
No abstract available

Publication types

  • Published Erratum